Charles River Labs will be hosting a webinar entitled “Next Generation Sequencing and Viral Safety: Questions, Answers and Case Studies” on Wednesday, May 17, 2017 from 11 a.m. to 12 noon Eastern Time featuring presentations by Pascale Beurdeley, PhD, PathoQuest’s Chief Scientific Officer and Charles Hébert, PhD, PathoQuest’s Chief Technology and Information Officer.
This webinar will provide insight on how PathoQuest’s Bioproduction Safety Testing Solution combines biological information obtained by Next Generation Sequencing (NGS) with the company’s propriety BioIT pipeline and database to aid in the identification of microorganisms. The webinar will also feature case studies on cell bank and virus stock characterization which demonstrate how the power of metagenomics is changing the paradigm for biosafety testing.
Charles River is a global leader in providing essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions be accelerate their research and drug development efforts. PathoQuest and Charles River have a preferred partnership agreement which provides Charles River’s customers access to PathoQuest’s NGS-based bioproduction safety testing solution.